Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editorial staff interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Venture capitalists will primarily direct their investments to the greentech and biotech industries during 2008, while China and India remain hot destinations for venture funds, according to a recent survey by the U.S. audit, tax, and advisory firm KPMG LLP.

During this week’s podcast, KPMG’s Brian Hughes and Packy Kelly talk about whom the company surveyed and discuss key findings of the study. They describe the major trends driving VC interest in emerging markets and in eco-friendly, life science, and medical technologies. Hughes and Kelly also provide details on the geographical areas in the U.S. where capital will be invested this year and comment on what investors foresee in terms of merger and acquisition activity in 2008.

(If you would like more information on KPMG’s VC survey after listening to the podcast, contact Manual Goncalves, email: [email protected])
Brian Hughes is the Partner-In-Charge of the Eastern Area Venture Capital practice for KPMG LLP. Brian has spent most of his 26-year career in public accounting serving technology and venture-backed companies. He has significant software industry experience and he has worked with over 25 companies to complete their IPOs. Brian is a founding member of the New Jersey Technology Council (NJTC) and a long-serving member of its Board of Directors. Brian holds a Bachelor of Science degree in Economics and an MBA from The Wharton School of the University of Pennsylvania.

Packy Kelly is the Partner-In-Charge of the Western Area and Silicon Valley Venture Capital practice for KPMG LLP. Packy has more than 18 years of experience providing auditing and accounting services, including IPOs for startups. Packy’s professional experience includes serving major semiconductor companies and working on six IPOs. He has been the lead engagement partner for several technology companies. Packy holds a Bachelor of Science degree in accounting from Fairfield University, an MBA from Columbia University, and an MBA from University of California-Berkeley. He is a member of the American Institute of Certified Public Accountants. He is also a member of the President’s Circle of Fairfield University. Packy has served on the advisory board to the MBA program at Notre Dame de Namur University and the MIT/Stanford Venture Lab.

Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »